10X Capital Venture Acquisition Corp. III Announces Expected Change in Management
January 08 2024 - 6:00AM
10X Capital Venture Acquisition Corp. III (“
10X
III”) (NYSE American:VCXB), a publicly traded special
purpose acquisition company, announced today that, subject to
approval by the board of directors, it expects David Weisburd, the
current Chief Operating Officer and Head of Origination, to succeed
Hans Thomas as Chief Executive Officer of 10X III, and expects
Osman Ahmed to succeed Oliver Wriedt as President. Mr. Thomas will
remain as Chairman of the board of directors.
About 10X Capital
10X Capital is an alternative asset management
firm leveraging advancements in data analytics & AI to generate
signals, deliver insights, and drive returns across asset
classes. 10X Capital is amongst the most active venture
capital firms globally, aligning Wall Street & Silicon Valley
by bringing institutional capital to high growth opportunities in
private & public markets. For more information, visit
https://www.10XCapital.com.
10X Capital Venture Acquisition Corp. III (NYSE
American: VCXB.U, VCXB, VCXB WS) is a special purpose acquisition
company sponsored by 10X Capital, focused on identifying high
growth businesses domestically and abroad and bringing them to the
public markets. For more information
visit https://www.10xspac.com/spaciii.
Additional Information and Where to Find
It
As previously announced on August 9, 2023, 10X
III has entered into a merger agreement with American Gene
Technologies International Inc., a Delaware corporation (“AGT”),
for a business combination that would result in the combined
company being a publicly listed company (the public company
following the business combination to be renamed “Addimmune”). In
connection with the proposed transaction, the parties have filed a
registration statement on Form S-4 (“Form S-4”), which includes a
proxy statement/prospectus of 10X III, along with other documents
regarding the proposed transaction. 10X III’s shareholders and
other interested persons are advised to read the preliminary proxy
statement/prospectus and the amendments thereto and the definitive
proxy statement and documents incorporated by reference therein
filed in connection with the proposed business combination, as
these materials will contain important information about AGT, 10X
III and the proposed business combination. Promptly after the Form
S-4 is declared effective by the SEC, 10X III will mail the
definitive proxy statement/prospectus and a proxy card to each
shareholder entitled to vote at the meeting relating to the
approval of the transactions and other proposals set forth in the
proxy statement/prospectus. The Form S-4, the proxy
statement/prospectus, as well as other filings containing
information about AGT and 10X III will be available without charge
at the SEC’s Internet site (http://www.sec.gov). Copies of the
definitive proxy statement/prospectus can be obtained, when
available, without charge, from 10X III’s
website https://www.10xspac.com/spaciii. BEFORE
MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS ARE URGED TO
CAREFULLY READ THE FORM S-4 AND THE PROXY
STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED OR THAT
WILL BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED BUSINESS
COMBINATION WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION ABOUT THE PROPOSED BUSINESS
COMBINATION.
Participants in the
Solicitation
AGT, 10X III and certain of their respective
directors, executive officers and other members of management and
employees may, under SEC rules, be deemed to be participants in the
solicitation of proxies from 10X III’s shareholders in connection
with the proposed business combination. You can find more
information about 10X III’s directors and executive officers in 10X
III’s Annual Report on Form 10-K, as amended, for the year ended
December 31, 2022 (the “Annual Report”), which was filed with the
SEC on May 22, 2023, as modified or supplemented by any Form 3 or
Form 4 filed with the SEC since the date of such filing. Additional
information regarding the participants in the proxy solicitation
and a description of their direct and indirect interests is
included in the proxy statement/prospectus. Shareholders, potential
investors and other interested persons should read the proxy
statement/prospectus carefully before making any voting or
investment decisions. You may obtain free copies of these documents
from the sources indicated above.
No Offer or Solicitation
This press release shall not constitute a
solicitation of a proxy, consent, or authorization with respect to
any securities or in respect of the proposed business combination.
This press release shall also not constitute an offer to sell or
the solicitation of an offer to buy any securities, nor shall there
be any sale of securities in any states or jurisdictions in which
such offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of any such
jurisdiction. No offering of securities shall be made except by
means of a prospectus meeting the requirements of Section 10 of the
Securities Act of 1933, as amended, or an exemption therefrom.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. We intend such forward-looking statements to be
covered by the safe harbor provisions for forward-looking
statements contained in Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. Forward-looking statements generally are accompanied by
words such as “will,” “expect,” “anticipated,” “estimated,”
“believe,” “intend,” “plan,” “projection,” “outlook” or words of
similar meaning. These forward-looking statements are not
guarantees of future performance, conditions or results, and
involve a number of known and unknown risks, uncertainties,
assumptions and other important factors, many of which are outside
10X III’s control, that could cause actual results or outcomes to
differ materially from those discussed in the forward-looking
statements. Important factors, among others, that may affect actual
results or outcomes include those factors discussed in the Annual
Report, any subsequent Quarterly Reports on Form 10-Q filed with
the SEC and in any subsequent filings with the SEC, including the
Form S-4 and the proxy statement/prospectus which forms a part
thereof relating to the business combination. 10X III does not
undertake any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by law.
Contact ir@10xcapital.com
10X Capital Venture Acqu... (AMEX:VCXB.U)
Historical Stock Chart
From Sep 2024 to Oct 2024
10X Capital Venture Acqu... (AMEX:VCXB.U)
Historical Stock Chart
From Oct 2023 to Oct 2024